A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) became a global human health threat since its first documentation in humans in 2012. An efficient vaccine for the prophylaxis of humans in hotspots of the infection (e.g., Saudi Arabia) is necessary but no commercial vaccines are yet approved....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pathogens
Main Authors: Shehata, Mahmoud M., Kandeil, Ahmed, Mostafa, Ahmed, Mahmoud, Sara H., Gomaa, Mokhtar R., El-Shesheny, Rabeh, Webby, Richard, Kayali, Ghazi, A. Ali, Mohamed
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963271/
https://ncbi.nlm.nih.gov/pubmed/31810359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pathogens8040281
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares